Search
Search Term

Hematologic Malignancies

HEMATOLOGIC
MALIGNANCIES

The Hematologic Malignancies (HEM) research program focuses on advancing our understanding of molecular pathogenesis and treatment of leukemias and lymphomas.

About the Program

MEMBERSHIP RESOURCES

BECOME A MEMBER

EVENTS

Program Highlights

Project EVOLVE: An international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia

Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement

Crohn's Disease-associated variant in laccase domain containing 1 (LACC1) modulates T cell gene expression, metabolism and T cell function

Inside the Lab: Researcher Spotlight with Hojun Li, MD, PhD